Molecular mechanism of preconditioning

IUBMB Life

Volumn 60, Issue 4, 2008, Pages 199-203

  Das, Manika ^a   Das, Dipak K ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; Cell death; Mycoardial infarction; Preconditioning

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; BRADYKININ; CYCLOOXYGENASE 2; G PROTEIN COUPLED RECEPTOR; HEAT SHOCK PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; OPIATE; PROSTAGLANDIN; PROTEIN KINASE C; PROTEIN TYROSINE KINASE;

CHANNEL GATING; GENE EXPRESSION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; ISCHEMIC PRECONDITIONING; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN SYNTHESIS; REVIEW; CYTOLOGY; HEART INFARCTION; HEART MUSCLE CELL; METABOLISM; PATHOLOGY; PHYSIOLOGY; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STUNNED HEART MUSCLE;

GENE EXPRESSION; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIAL STUNNING; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 45549098351     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.31     Document Type: Review

References (40)

1. Murry, C. E., Jennings, R. B., and Reimer, K. A. (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136.
2. Bolli, R. (2000) The late phase of preconditioning. Circ. Res. 87, 972-983.
3. Yellen, D. M., and Downey, J. M. (2003) Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol. Rev. 83, 1131-1151.
4. Speechly-Dick, M. E., Mocanu, M. M., and Yellon, D. M. (1994) Protein kinase C. Its role in ischemic preconditioning in the rat. Circ. Res. 75, 586-590.
5. 21-and phos-pholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc. Natl. Acad. Sci. USA 86, 6758-6762.
6. Von Ruecker, A. A., Han-Jeon, B. G., Wild, M., and Bidlingmaier, F. (1989) Protein kinase C involvement in lipid peroxidation and cell damage induced by oxygen de-rived radicals in hepatocytes. Biochem. Biophys. Res. Commun. 163, 836-842.
7. Brooks, G., and Hearse, D. J. (1996) Role of protein kinase C in ischemic preconditioning: player or spectator? Circ. Res. 79, 627-630.
8. Natarajan, V., Vespa, S., Shamlal, R., Al-Hassani, M., Ramasarma, T., Ravishiankar, H. N., and Scribner, W. N. (1998) Tyrosine kinase and calcium dependent activation of endothelial cell phospholipase D by diperoxyvandate. Mol. Cell. Biochem. 183, 113-124.
9. Nitric oxide-cGMP-protein kinase G signaling pathway induces anoxic preconditioning in rat hearts. Am. J. Physiol. Heart Circ. Physiol. 2006, 290, H1808-H1817.
10. Seko, Y., Tobe, K., Takahashi, N., Kaburagi, Y., Kadoyaki, T., and Yazaki, Y. (1996) Hypoxia and Hypoxia reoxygenation activate Src family Tyrosine kinase and p21ras in cultered cardiac myocytes. Biochem. Biophys. Res. Common. 226, 530-535.
11. Song, C., Vondriska, T. M., Wang, G. W., Klein, J. B., Cao, X., Zhang, J., and Ping, P. (2002) Molecular conformation dictates signaling module formation: example of PKC epsilon and Src tyrosine kinase. Am. J. Physiol. Heart Circ. Physiol. 292, H1166-H1171.
12. Seger, R., and Krebs, E. G. (1995) The MAPK signaling cascade. FASEB J. 9, 726-735.
13. Cobb, M. H., and Goldsmith, E. J. (1995) How MAP kinases are regulated? J. Biol. Chem. 270, 14843-14846.
14. Maulik, N., Watanabe, M., Zu, Y. L., Huang, C. K., Cordis, G. A., Schley, J. A., and Das, D. K. (1996) Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett. 396, 233-237.
15. Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., and Woodgett, J. D. (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369, 156-160.
16. Maulik, N., Yoshida, T., Zu, Y. L., Sato, M., Banerjee, A., and Das, D. K. (1998) Ischemic preconditioning triggers tyrosine kinase signaling: potential role for MAPKAP kinase 2. Am. J. Physiol. 275, H1857-H1864.
17. Nagy, N., Shiroto, K., Malik, G., Huang, C. K., Gaestel, M., Abdellatif, M., Tosaki, A., Maulik, N., Das, D. K. (2007) Ischemic preconditioning involves dual cardio-protective axes with p38MAPK as upstream target. J. Mol. Cell. Cardiol. 42, 981-990.
18. Honda, H. M., and Ping, P. (2006) Mitochondrial permeability transition in cardiac cell injury and death. Cardiovasc. Drugs. Ther. 20, 425-432.
19. IONA. 2002. Effect of nicorandil on coronary events in patients with stable angina: the impact of Nicorandil in Angina (IONA) randomized trial. Lancet 9541, 1267-1275.
20. Rizvi, A., Tang, X. L., Qiu, Y., Xuan, Y. T., Jadoon, A. K., and Bolli, R. (1999) Increased protein synthesis is necessary for the late preconditioning against myocardial stunning. Am. J. Physiol. 277, H874-H884.
21. Marber, M. S., Latchman, D. S., Walker, D. M., and Yellow, D. M. (1993) Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88, 1264-1272.
22. Maulik, N., Sato, M., Price, B. D., and Das, D. K. (1998) An essential role of NF-kB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett. 429, 365-369.
23. Bolli, R., Shinmura, K., Tang, X. L., Kodani, E., Xuan, Y. T., Guo, Y., and Dawn, B. (2002) Discovery of new function of cyclooxygenase (Cox) 2. Cardiovasc. Res. 55, 506-519.
24. Maulik, N., Goswami, S., Galang, N., and Das, D. K. (1999) Differential regulation of bcl-2, AP-1 and NFkB on cardiomyocyte apoptosis during myocardial ischemic stress adaptation. FEBS Lett. 443, 331-336.
25. McMahon, S. B., Monroe, J. G. (1992) Role of primary response genes in generating cellular responses to growth factors. FASEB J. 62, 2707-2715.
26. Artuc, M., Karman, D., Jurgovsky, K., and Schadendorf, D. (1997) Humanmelonoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindestine or etoposide: modulation of proto-oncogene expression. Anticancer 17, 4359-4370.
27. Hughes, P. E., Alexi, T., Yoshida, T., Schreiber, S. S., and Knusel, B. (1996) Excitotoxic lesion of rat brain with quinolinic acid induces expression of p53 messenger RNA and protein and p53 inducible genes BAX and GADD-45 brain areas showing DNA fragmentation. Neuroscience 74, 1143-1160.
28. Thornberry, N. A., and Lazebnik, Y. (1998) Caspases: enemies within. Science 281, 1312-1316.
29. Ihle, J. N. (2002) STATs: signal transducers and activators of transcription. Cell 84, 331-334.
30. Mc Whinney, C. D., Hunt, R. A., Conrad, K. M., Dostal, D. E., and Baker, K. M. (1997) The type I angiotensin II receptor couples to STAT1 and STAT 3 activation through JAK2 kinase in neonatal rat cardiac myocytes. J. Mol. Cell. Cardiol. 29, 2513-2524.
31. Negoro, S., Kunisada, K., Tone, E., Funamoto, M., Oh, H., Kishimoto, T., and Yamauchi-Takihara, K. (2000) Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infraction. Cardiovasc. Res. 47, 797-805.
32. Stephanou, A., Brar, B. K., Scarabelli, T. M., Jonassen, A. K., Yellon, D. M., Marber, M. S., Knight, R. A., and Latchman, D. S. (2000) Ischemia-induced Stat-1 expression and activation play a crucial role in cardiomyocyte apoptosis. J. Biol. Chem. 273, 10002-10008.
33. Booli, R. (2000) The late phase of preconditioning. Circ Res 87, 972-983.
34. Arner, E. S. J., and Holmgren, A. (2000) Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267, 6102-6109.
35. Prieto-Alamo, M. J., Jurado, J., and Gallardo-Madueno, R. (2000) Transcriptional regulation of glutaredoxin and thioredoxin pathways and related enzymes in response to oxidative stress. J. Biol. Chem. 275, 13398-13405.
36. Nakamura, H., Vaage, J., and Valen, G. (1998) Measurements of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery. Free Radic. Biol. Med. 24, 1176-1186.
37. Turoczi, T., Chang, V. W., Engelman, R. M., Maulik, N., Ho, Y. S., and Das, D. K. (2003) Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1. J. Mol. Cell Cardiol. 35, 695-704.
38. Redox activation of Ref-1 potentiates cell survival following myocardial ischemia reperfusion injury. Free Radic. Biol. Med. 2007, 43, 397-404.
39. Malik, G., Nagy, N., Ho, Y. S., Maulik, N., and Das, D. K. (2008) Role of Glutarodoxin-1 in cardioprotection: an insight with Glrx1 and knock-out animals. J. Mol. Cell Cardiol. 44, 261-269.
40. Nagy, N., Malik, G., Tosaki, A., Ho, Y. S., Maulik, N., and Das, D. K. (2008) Overexpression of Gluterodoxin-2 reduces myocardial cell death by preventing both apoptosis and necrosis. J. Mol. Cell Cardiol. 44, 252-260.